Cell-Based Noninvasive Prenatal Testing
Status unconfirmed · Not applicable
Conditions studied: Pregnancy Related
In brief
The purpose of the overall study is to develop improved methods for recovery and analysis of fetal cells from the mother's blood in order to develop clinically useful forms of cell-based, diagnostic, noninvasive prenatal testing (NIPT). Luna genetics will obtain and analyze research blood samples from healthy pregnant women. A phlebotomist will be sent to any location in the United States to collect the blood samples. Sample identifiers will be removed as the first step so that laboratory personnel will not see or have access to identifiers.
Key facts
- Study ID
- NCT05245266
- Run by
- Luna Genetics
- People needed
- 500
- Starts
- 2022-01-12
- Expected to finish
- 2024-03-12
- Last updated by the study team
- 2023-03-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Luna Genetics — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.